BOSTON, MASSACHUSETTS, Jan. 07, 2025 (GLOBE NEWSWIRE) -- (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, ...
For the first time in 17 years, at the close of 2024 pension plans sponsored by large U.S. companies were fully funded to ...